Table II.
Effect of focused-extracorporeal shock wave therapy on pain and function measures
| Variable | Group A | Group B | Group C | Group D |
|---|---|---|---|---|
| Tau-U weighted mean (p value) – baseline to intervention | ||||
| WOMAC ALF PPT |
0.50 (0.046)* –0.38 (0.13) 0.04 (0.87) |
–0.63 (0.006)* –0.53 (0.019)* 0.69 (0.02)* |
–0.43 (0.107) –0.62 (0.016)* 0.14 (0.58) |
–0.72 (0.002)* –0.799 (0.001)* 0.07 (0.752) |
| Tau-U weighted mean (p value) – intervention to follow-up | ||||
| WOMAC ALF PPT |
–0.58 (0.02)* 0.08 (0.74) 0.00 (1.00) |
–0.83 (0.000)* –0.72 (0.001)* 0.028 (0.90) |
0.62 (0.016)* 0.03 (0.91) 0.23 (0.36) |
–0.25 (0.27) –0.03 (0.90) 0.03 (0.90) |
| Tau-U weighted mean (p value) – baseline to follow-up | ||||
| WOMAC ALF PPT |
–0.13 (0.62) –0.71 (0.005)* –0.08 (0.73) |
–0.88 (0.000)* –0.77 (0.002)* 0.54 (0.03)* |
0.22 (0.385) –0.25 (0.317) 0.33 (0.18) |
–0.74 (0.004)* –0.91 (0.000)* –0.01 (0.97) |
*
Denote statistical significance (p<0.05).
WOMAC: Western Ontario and McMaster Universities Osteoarthritis index; ALF: aggregated locomotor function; PPT: Pressure pain threshold.